Regular Article
Selective Inhibition of Cyclooxygenase-2 by C-Phycocyanin, a Biliprotein from Spirulina platensis

https://doi.org/10.1006/bbrc.2000.3725Get rights and content

Abstract

We report data from two related assay systems (isolated enzyme assays and whole blood assays) that C-phycocyanin a biliprotein from Spirulina platensis is a selective inhibitor of cyclooxygenase-2 (COX-2) with a very low IC50 COX-2/IC50 COX-1 ratio (0.04). The extent of inhibition depends on the period of preincubation of phycocyanin with COX-2, but without any effect on the period of preincubation with COX-1. The IC50 value obtained for the inhibition of COX-2 by phycocyanin is much lower (180 nM) as compared to those of celecoxib (255 nM) and rofecoxib (401 nM), the well-known selective COX-2 inhibitors. In the human whole blood assay, phycocyanin very efficiently inhibited COX-2 with an IC50 value of 80 nM. Reduced phycocyanin and phycocyanobilin, the chromophore of phycocyanin are poor inhibitors of COX-2 without COX-2 selectivity. This suggests that apoprotein in phycocyanin plays a key role in the selective inhibition of COX-2. The present study points out that the hepatoprotective, anti-inflammatory, and anti-arthritic properties of phycocyanin reported in the literature may be due, in part, to its selective COX-2 inhibitory property, although its ability to efficiently scavenge free radicals and effectively inhibit lipid peroxidation may also be involved.

References (37)

  • W.L. Smith et al.

    J. Biol. Chem.

    (1996)
  • K.B. Cummings et al.

    J. Urol.

    (1977)
  • E.A. Meade et al.

    J. Biol. Chem.

    (1993)
  • T. Kumagai et al.

    Biochem. Biophys. Res. Commun.

    (2000)
  • B.B. Vadiraja et al.

    Biochem. Biophys. Res. Commun.

    (1998)
  • R. Gonzalez et al.

    Pharmacol. Res.

    (1999)
  • L.A. Flugge et al.

    Chem. Biol.

    (1999)
  • F.R. Trull et al.

    Arch. Biochem. Biophys.

    (1992)
  • M. Hemler et al.

    J. Biol. Chem.

    (1976)
  • M.M. Bradford

    Anal. Biochem.

    (1976)
  • L.J. Marnett et al.

    Trends Pharmacol. Sci.

    (1999)
  • K. Subbaramaiah et al.

    J. Biol. Chem.

    (1998)
  • W.L. Xie et al.

    Proc. Natl. Acad. Sci. USA

    (1991)
  • D.B. Fournier et al.

    J. Cell. Biochem. Suppl.

    (2000)
  • J.R. Vane et al.

    Annu. Rev. Pharmacol. Toxicol.

    (1998)
  • J.R. Vane

    Nature (London) New Biol.

    (1971)
  • T.F. Slater et al.

    Phil. Trans. R. Soc. Lond. B.

    (1985)
  • S. Basu

    Biochem. Biophys. Res. Commun.

    (1999)
  • Cited by (0)

    1

    To whom correspondence should be addressed. Fax: 091-080-3600529. E-mail: [email protected].

    View full text